ArticleFrontiers in oncology2021

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.

Li Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.